Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,805.38 -141.55 (-0.36%) Hang Seng
19,220.62 -415.60 (-2.12%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
70,128.93 -1,228.99 (-1.72%) CMC Crypto 200
1,526.99 +38.45 (+2.58%)
Rhythm Biosciences Limited (RHY.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
As of 10:17AM AEST. Market open.
Currency in AUD
Valuation measures4
| Market cap (intra-day) | 16.90M |
| Enterprise value | 15.68M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 13.60 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -24.80 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.70 |
| 52-week change 3 | -84.89% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 0.5550 |
| 52-week low 3 | 0.0660 |
| 50-day moving average 3 | 0.0881 |
| 200-day moving average 3 | 0.1737 |
Share statistics
| Avg vol (3-month) 3 | 117.02k |
| Avg vol (10-day) 3 | 104.33k |
| Shares outstanding 5 | 248.6M |
| Implied shares outstanding 6 | 268.7M |
| Float 8 | 151.71M |
| % held by insiders 1 | 29.85% |
| % held by institutions 1 | 4.74% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -244.33% |
Management effectiveness
| Return on assets (ttm) | -91.64% |
| Return on equity (ttm) | -171.97% |
Income statement
| Revenue (ttm) | 2.07M |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | -37.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -8.68M |
| Net income avi to common (ttm) | -8.63M |
| Diluted EPS (ttm) | -0.0400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.26M |
| Total cash per share (mrq) | 0.01 |
| Total debt (mrq) | 38.94k |
| Total debt/equity (mrq) | 3.13% |
| Current ratio (mrq) | 2.05 |
| Book value per share (mrq) | 0.01 |
Cash flow statement
| Operating cash flow (ttm) | -8.21M |
| Levered free cash flow (ttm) | -5.17M |
© 2024 Yahoo. All rights reserved.